Citi Opens Catalyst Watch on Summit Therapeutics plc (SMMT)
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz reiterated a Buy rating and $40.00 price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
